{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:31:44Z","timestamp":1794609104573,"version":"4.9.1"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004242","name":"Princess Nourah Bint Abdulrahman University","doi-asserted-by":"publisher","award":["PNURSP2026R456"],"award-info":[{"award-number":["PNURSP2026R456"]}],"id":[{"id":"10.13039\/501100004242","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-61161-x","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T03:09:50Z","timestamp":1783480190000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Integrative immunoinformatics and structural modeling for the rational design of a multi-epitope vaccine candidate against human cytomegalovirus"],"prefix":"10.1038","volume":"16","author":[{"given":"Owona Pascal","family":"Emmanuel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengue Ngadena Yolande","family":"Sandrine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilanda Danielle","family":"Claude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akingbolabo Daniel","family":"Ogunlakin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bidingha A. Goudani","family":"Ronald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dzeufiet Djomeni Paul","family":"Desire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha A.","family":"Aljumaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaza N.","family":"Alkhatib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan Abdulrahman","family":"Sagini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"61161_CR1","doi-asserted-by":"publisher","unstructured":"Sharma, U. et al. Human Cytomegalovirus: An Insight of Its Pathobiology and Therapeutics. Emerging Human Viral Diseases, Volume II. https:\/\/doi.org\/10.1007\/978-981-97-4480-0_23 (Springer, 2024).","DOI":"10.1007\/978-981-97-4480-0_23"},{"key":"61161_CR2","doi-asserted-by":"publisher","first-page":"1636978","DOI":"10.3389\/fimmu.2025.1636978","volume":"16","author":"Y Xia","year":"2026","unstructured":"Xia, Y. et al. Recent advances in human cytomegalovirus: a comprehensive review of pathogenic mechanisms, virus-host interactions, and antiviral strategies. Front. Immunol. 16, 1636978. https:\/\/doi.org\/10.3389\/fimmu.2025.1636978 (2026).","journal-title":"Front. Immunol."},{"issue":"5","key":"61161_CR3","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3390\/microorganisms8050685","volume":"8","author":"F Gugliesi","year":"2020","unstructured":"Gugliesi, F. et al. Where do we stand after decades of studying human cytomegalovirus? Microorganisms 8(5), 685. https:\/\/doi.org\/10.3390\/microorganisms8050685 (2020).","journal-title":"Microorganisms"},{"issue":"1","key":"61161_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13643-022-02004-4","volume":"11","author":"SJ Balegamire","year":"2022","unstructured":"Balegamire, S. J. et al. Prevalence, incidence, and risk factors associated with cytomegalovirus infection in healthcare and childcare workers: a systematic review and meta-analysis. Syst. Rev. 11(1), 131. https:\/\/doi.org\/10.1186\/s13643-022-02004-4 (2022).","journal-title":"Syst. Rev."},{"issue":"3","key":"61161_CR5","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S2055-6640(20)30456-8","volume":"2","author":"M Bates","year":"2016","unstructured":"Bates, M. & Brants\u00e6ter, A. B. Human cytomegalovirus (CMV) in Africa: a neglected but important pathogen. J. Virus Erad. 2(3), 136\u2013142. https:\/\/doi.org\/10.1016\/S2055-6640(20)30456-8 (2016).","journal-title":"J. Virus Erad"},{"key":"61161_CR6","doi-asserted-by":"publisher","unstructured":"Bates, M., Musonda, K. & Zumla, A. Human cytomegalovirus infection in Sub-Saharan Africa. In Manifestations of Cytomegalovirus Infection. https:\/\/doi.org\/10.5772\/54907 (InTech, 2013).","DOI":"10.5772\/54907"},{"key":"61161_CR7","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1186\/s12889-022-13971-7","volume":"22","author":"K Fowler","year":"2022","unstructured":"Fowler, K. et al. A systematic literature review of the global seroprevalence of cytomegalovirus. BMC Public. Health. 22, 1659. https:\/\/doi.org\/10.1186\/s12889-022-13971-7 (2022).","journal-title":"BMC Public. Health"},{"issue":"4","key":"61161_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3390\/pathogens8040213","volume":"8","author":"H Al Mana","year":"2019","unstructured":"Al Mana, H. et al. The current status of cytomegalovirus prevalence in the MENA region. Pathogens 8(4), 213. https:\/\/doi.org\/10.3390\/pathogens8040213 (2019).","journal-title":"Pathogens"},{"key":"61161_CR9","doi-asserted-by":"publisher","first-page":"1359663","DOI":"10.3389\/fpubh.2024.1359663","volume":"12","author":"H Payne","year":"2024","unstructured":"Payne, H. & Barnabas, S. Congenital cytomegalovirus in Sub-Saharan Africa\u2014a narrative review. Front. Public. Health. 12, 1359663. https:\/\/doi.org\/10.3389\/fpubh.2024.1359663 (2024).","journal-title":"Front. Public. Health"},{"key":"61161_CR10","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1186\/s12879-025-10957-9","volume":"25","author":"CH Hsu","year":"2025","unstructured":"Hsu, C. H. et al. Clinical presentation of cytomegalovirus meningoencephalitis. BMC Infect. Dis. 25, 575. https:\/\/doi.org\/10.1186\/s12879-025-10957-9 (2025).","journal-title":"BMC Infect. Dis."},{"issue":"5","key":"61161_CR11","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3390\/children12050613","volume":"12","author":"A Cradeur","year":"2025","unstructured":"Cradeur, A. et al. Congenital cytomegalovirus infection as a leading cause of pediatric hearing loss. Child. (Basel). 12(5), 613. https:\/\/doi.org\/10.3390\/children12050613 (2025).","journal-title":"Child. (Basel)"},{"issue":"2","key":"61161_CR12","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/cmi.2014.75","volume":"12","author":"MR Wills","year":"2015","unstructured":"Wills, M. R., Poole, E., Lau, B., Krishna, B. & Sinclair, J. H. The immunology of human cytomegalovirus latency. Cell. Mol. Immunol. 12(2), 128\u2013138. https:\/\/doi.org\/10.1038\/cmi.2014.75 (2015).","journal-title":"Cell. Mol. Immunol."},{"issue":"6","key":"61161_CR13","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.3390\/v15061358","volume":"15","author":"K Panda","year":"2023","unstructured":"Panda, K., Parashar, D. & Viswanathan, R. An update on current antiviral strategies to combat HCMV infection. Viruses 15(6), 1358. https:\/\/doi.org\/10.3390\/v15061358 (2023).","journal-title":"Viruses"},{"issue":"10","key":"61161_CR14","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.3390\/microorganisms11102372","volume":"11","author":"P Bottino","year":"2023","unstructured":"Bottino, P. et al. Antiviral approach to cytomegalovirus infection. Microorganisms 11(10), 2372. https:\/\/doi.org\/10.3390\/microorganisms11102372 (2023).","journal-title":"Microorganisms"},{"issue":"1","key":"61161_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3390\/idr16010005","volume":"16","author":"J Piret","year":"2024","unstructured":"Piret, J. & Boivin, G. Management of cytomegalovirus infections in the era of novel antivirals. Infect. Dis. Rep. 16(1), 65\u201382. https:\/\/doi.org\/10.3390\/idr16010005 (2024).","journal-title":"Infect. Dis. Rep."},{"issue":"5","key":"61161_CR16","doi-asserted-by":"publisher","first-page":"504","DOI":"10.2174\/187152611797636668","volume":"11","author":"SH James","year":"2011","unstructured":"James, S. H. & Prichard, M. N. Genetic basis of human cytomegalovirus resistance. Infect. Disord Drug Targets. 11(5), 504\u2013513. https:\/\/doi.org\/10.2174\/187152611797636668 (2011).","journal-title":"Infect. Disord Drug Targets"},{"issue":"8","key":"61161_CR17","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1093\/cid\/ciy696","volume":"68","author":"RF Chemaly","year":"2019","unstructured":"Chemaly, R. F. et al. Definitions of resistant and refractory cytomegalovirus infection. Clin. Infect. Dis. 68(8), 1420\u20131426. https:\/\/doi.org\/10.1093\/cid\/ciy696 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"61161_CR18","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2147\/IDR.S79131","volume":"8","author":"DP Melendez","year":"2015","unstructured":"Melendez, D. P. & Razonable, R. R. Letermovir and inhibitors of CMV terminase complex. Infect. Drug Resist. 8, 269\u2013277. https:\/\/doi.org\/10.2147\/IDR.S79131 (2015).","journal-title":"Infect. Drug Resist."},{"key":"61161_CR19","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-78-8-1981","author":"C Smuda","year":"1997","unstructured":"Smuda, C., Bogner, E. & Radsak, K. The human cytomegalovirus glycoprotein B gene (ORF UL55) is expressed early in the infectious cycle. J. Gen. Virol. https:\/\/doi.org\/10.1099\/0022-1317-78-8-1981 (1997). 78(Pt 8), 1981\u20131992.","journal-title":"J. Gen. Virol."},{"issue":"8","key":"61161_CR20","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1128\/JVI.01251-08","volume":"83","author":"MK Isaacson","year":"2009","unstructured":"Isaacson, M. K. & Compton, T. Human cytomegalovirus glycoprotein B is required for virus entry and cell-to-cell spread but not for virion attachment, assembly, or egress. J. Virol. 83(8), 3891\u20133903. https:\/\/doi.org\/10.1128\/JVI.01251-08 (2009).","journal-title":"J. Virol."},{"key":"61161_CR21","doi-asserted-by":"publisher","unstructured":"Tang, J., Frascaroli, G., Lebbink, R. J., Ostermann, E. & Brune, W. Human cytomegalovirus glycoprotein B variants affect viral entry, cell fusion, and genome stability. Proc. Natl. Acad. Sci. USA. 116(36), 18021\u201318030. https:\/\/doi.org\/10.1073\/pnas.1907447116 (2019).","DOI":"10.1073\/pnas.1907447116"},{"issue":"6","key":"61161_CR22","doi-asserted-by":"publisher","first-page":"e0217824","DOI":"10.1128\/jvi.02178-24","volume":"99","author":"KP Karthigeyan","year":"2025","unstructured":"Karthigeyan, K. P. et al. A human cytomegalovirus prefusion-like glycoprotein B subunit vaccine elicits humoral immunity similar to that of postfusion gB in mice. J. Virol. 99(6), e0217824. https:\/\/doi.org\/10.1128\/jvi.02178-24 (2025).","journal-title":"J. Virol."},{"issue":"8","key":"61161_CR23","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.4049\/jimmunol.15006963","volume":"195","author":"A Pachnio","year":"2015","unstructured":"Pachnio, A., Zuo, J., Ryan, G. B., Begum, J. & Moss, P. A. The cellular localization of human cytomegalovirus glycoprotein expression greatly influences CD4\u2009+\u2009T cell responses. J. Immunol. 195(8), 3803\u20133815. https:\/\/doi.org\/10.4049\/jimmunol.15006963 (2015).","journal-title":"J. Immunol."},{"issue":"5","key":"61161_CR24","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3390\/vaccines13050435","volume":"13","author":"A Lankina","year":"2025","unstructured":"Lankina, A. et al. Developing a vaccine against human cytomegalovirus: identifying and targeting HCMV\u2019s immunological Achilles\u2019 heel. Vaccines 13(5), 435. https:\/\/doi.org\/10.3390\/vaccines13050435 (2025).","journal-title":"Vaccines"},{"key":"61161_CR25","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1038\/s41467-023-36683-x","volume":"14","author":"AC Gomes","year":"2023","unstructured":"Gomes, A. C. et al. The cytomegalovirus gB\/MF59 vaccine candidate induces antibodies against an antigenic domain controlling cell-to-cell spread. Nat. Commun. 14, 1041. https:\/\/doi.org\/10.1038\/s41467-023-36683-x (2023).","journal-title":"Nat. Commun."},{"issue":"12","key":"61161_CR26","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1093\/infdis\/jiy102","volume":"217","author":"I Baraniak","year":"2018","unstructured":"Baraniak, I. et al. Epitope-specific humoral responses to HCMV gB vaccine with MF59. J. Infect. Dis. 217(12), 1907\u20131917. https:\/\/doi.org\/10.1093\/infdis\/jiy102 (2018).","journal-title":"J. Infect. Dis."},{"issue":"3","key":"61161_CR27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1080\/20477724.2018.1446773","volume":"112","author":"A Kazi","year":"2018","unstructured":"Kazi, A. et al. Immunoinformatics approach for vaccine design. Pathogens Glob Health. 112(3), 123\u2013131. https:\/\/doi.org\/10.1080\/20477724.2018.1446773 (2018).","journal-title":"Pathogens Glob Health"},{"key":"61161_CR28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00438-026-02376-5","volume":"301","author":"M Naveed","year":"2026","unstructured":"Naveed, M. et al. Immunoinformatics-guided multi-epitope vaccine against Oropouche virus. Mol. Genet. Genomics. 301, 43. https:\/\/doi.org\/10.1007\/s00438-026-02376-5 (2026).","journal-title":"Mol. Genet. Genomics"},{"key":"61161_CR29","doi-asserted-by":"publisher","first-page":"4100","DOI":"10.1038\/s41598-026-35434-4","volume":"16","author":"M Naveed","year":"2026","unstructured":"Naveed, M. et al. Immunoinformatics-based vaccine against Vibrio fluvialis. Sci. Rep. 16, 4100. https:\/\/doi.org\/10.1038\/s41598-026-35434-4 (2026).","journal-title":"Sci. Rep."},{"issue":"7","key":"61161_CR30","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1080\/07391102.2020.1850357","volume":"40","author":"VST Ayyagari","year":"2022","unstructured":"Ayyagari, V. S. T., C., K., Srirama, K. & A. P. & Multi-epitope vaccine design targeting SARS-CoV-2\u00a0M protein. J. Biomol. Struct. Dyn. 40(7), 2963\u20132977. https:\/\/doi.org\/10.1080\/07391102.2020.1850357 (2022).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"61161_CR31","doi-asserted-by":"publisher","first-page":"101782","DOI":"10.1016\/j.biologicals.2024.101782","volume":"87","author":"R Biswas","year":"2024","unstructured":"Biswas, R. et al. Integrative immunoinformatics pipeline for HCMV multi-epitope vaccine design. Biologicals 87, 101782. https:\/\/doi.org\/10.1016\/j.biologicals.2024.101782 (2024).","journal-title":"Biologicals"},{"key":"61161_CR32","doi-asserted-by":"publisher","first-page":"22610","DOI":"10.1038\/s41598-025-07433-4","volume":"15","author":"C Aram","year":"2025","unstructured":"Aram, C., Karami, L. & Ranjbar, M. M. mRNA vaccine design targeting VP4 of rotavirus A. Sci. Rep. 15, 22610. https:\/\/doi.org\/10.1038\/s41598-025-07433-4 (2025).","journal-title":"Sci. Rep."},{"key":"61161_CR33","doi-asserted-by":"publisher","first-page":"6949","DOI":"10.1038\/s41467-025-62139-5","volume":"16","author":"K Elez","year":"2025","unstructured":"Elez, K. et al. Simulation and active learning for antiviral discovery. Nat. Commun. 16, 6949. https:\/\/doi.org\/10.1038\/s41467-025-62139-5 (2025).","journal-title":"Nat. Commun."},{"key":"61161_CR34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2105-8-4","volume":"8","author":"IA Doytchinova","year":"2007","unstructured":"Doytchinova, I. A. & Flower, D. R. VaxiJen: prediction of protective antigens. BMC Bioinform. 8, 4. https:\/\/doi.org\/10.1186\/1471-2105-8-4 (2007).","journal-title":"BMC Bioinform"},{"key":"61161_CR35","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12985-025-02764-0","volume":"22","author":"SK Mishra","year":"2025","unstructured":"Mishra, S. K. et al. Integrated immuno- and bioinformatics-assisted novel epitope vaccine against HIV infection. Virol. J. 22, 228. https:\/\/doi.org\/10.1186\/s12985-025-02764-0 (2025).","journal-title":"Virol. J."},{"key":"61161_CR36","doi-asserted-by":"publisher","first-page":"1540253","DOI":"10.3389\/fimmu.2025.1540253","volume":"16","author":"SK Mishra","year":"2025","unstructured":"Mishra, S. K. et al. Mutation-based immunoinformatic approach incorporating epitope variability in HIV subtype C. Front. Immunol. 16, 1540253. https:\/\/doi.org\/10.3389\/fimmu.2025.1540253 (2025).","journal-title":"Front. Immunol."},{"issue":"4","key":"61161_CR37","doi-asserted-by":"publisher","first-page":"bbaa294","DOI":"10.1093\/bib\/bbaa294","volume":"22","author":"N Sharma","year":"2021","unstructured":"Sharma, N. et al. AlgPred 2.0 for allergen prediction. Brief. Bioinform. 22(4), bbaa294. https:\/\/doi.org\/10.1093\/bib\/bbaa294 (2021).","journal-title":"Brief. Bioinform"},{"key":"61161_CR38","doi-asserted-by":"publisher","DOI":"10.1101\/2024.07.23.604887","author":"AS Rathore","year":"2024","unstructured":"Rathore, A. S., Jain, S. & Raghava, G. P. Prediction of neurotoxin peptides. bioRxiv https:\/\/doi.org\/10.1101\/2024.07.23.604887 (2024).","journal-title":"bioRxiv"},{"key":"61161_CR39","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s11274-026-05022-9","volume":"42","author":"M Asim","year":"2026","unstructured":"Asim, M. et al. Immunoinformatics-based vaccine against Bacillus cereus. World J. Microbiol. Biotechnol. 42, 290. https:\/\/doi.org\/10.1007\/s11274-026-05022-9 (2026).","journal-title":"World J. Microbiol. Biotechnol."},{"issue":"3","key":"61161_CR40","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1006\/jmbi.2000.4315","volume":"305","author":"A Krogh","year":"2001","unstructured":"Krogh, A., Larsson, B., von Heijne, G. & Sonnhammer, E. L. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J. Mol. Biol. 305(3), 567\u2013580. https:\/\/doi.org\/10.1006\/jmbi.2000.4315 (2001).","journal-title":"J. Mol. Biol."},{"issue":"1","key":"61161_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-26511-1","volume":"15","author":"M Zahraei","year":"2025","unstructured":"Zahraei, M., Roohparvar Basmenj, E., Behrouzi, G., Heidari Keshel, S. & Alem, M. In silico design of a multi-epitope vaccine against the triple negative breast cancer. Sci. Rep. 15(1), 42425. https:\/\/doi.org\/10.1038\/s41598-025-26511-1 (2025).","journal-title":"Sci. Rep."},{"issue":"12","key":"61161_CR42","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.14202\/vetworld.2016.1364-1369","volume":"9","author":"SS Patil","year":"2016","unstructured":"Patil, S. S. et al. Phylogenetic analysis of glycoprotein B gene sequences of bovine herpesvirus 1 isolates from India reveals the predominance of subtype 1.1. Veterinary world. 9(12), 1364\u20131369. https:\/\/doi.org\/10.14202\/vetworld.2016.1364-1369 (2016).","journal-title":"Veterinary world"},{"issue":"5","key":"61161_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering11050480","volume":"11","author":"Y Zou","year":"2024","unstructured":"Zou, Y. et al. Common methods for phylogenetic tree construction and their implementation in R. Bioengineering (Basel, Switzerland) 11(5), 480. https:\/\/doi.org\/10.3390\/bioengineering11050480 (2024).","journal-title":"Bioengineering (Basel, Switzerland)"},{"key":"61161_CR44","doi-asserted-by":"publisher","unstructured":"Hall, B. G. Building phylogenetic trees from molecular data with MEGA. Mol. Biol. Evol. 30(5), 1229\u20131235. https:\/\/doi.org\/10.1093\/molbev\/mst012 (2013).","DOI":"10.1093\/molbev\/mst012"},{"issue":"5","key":"61161_CR45","doi-asserted-by":"publisher","first-page":"176","DOI":"10.31083\/j.fbl2905176","volume":"29","author":"M Tariq Aziz","year":"2024","unstructured":"Tariq Aziz, M. et al. Designing a multiepitope vaccine against the foodborne pathogenic bacteria Listeria monocytogenes using subtractive immunoinformatics approaches. Front. Biosci. (Landmark Ed). 29(5), 176. https:\/\/doi.org\/10.31083\/j.fbl2905176 (2024).","journal-title":"Front. Biosci. (Landmark Ed)"},{"issue":"1","key":"61161_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-96989-2","volume":"15","author":"M Naveed","year":"2025","unstructured":"Naveed, M. et al. Computational design of a glycosylated multi-epitope vaccine against HAsV-1 and HAsV-2 astrovirus for acute gastroenteritis. Sci. Rep. 15(1), 13954. https:\/\/doi.org\/10.1038\/s41598-025-96989-2 (2025).","journal-title":"Sci. Rep."},{"issue":"9","key":"61161_CR47","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.4049\/jimmunol.1700893","volume":"199","author":"V Jurtz","year":"2017","unstructured":"Jurtz, V. et al. NetMHCpan-4.0: Improved peptide-MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data. Journal of immunology (Baltimore, Md.\u202f: 1950) 199(9), 3360\u20133368. https:\/\/doi.org\/10.4049\/jimmunol.1700893 (2017).","journal-title":"Journal of immunology (Baltimore, Md. : 1950)"},{"issue":"5","key":"61161_CR48","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbac174","volume":"23","author":"N Sharma","year":"2022","unstructured":"Sharma, N., Naorem, L. D., Jain, S. & Raghava, G. P. S. ToxinPred2: An improved method for predicting toxicity of proteins. Brief. Bioinform. 23(5), bbac174. https:\/\/doi.org\/10.1093\/bib\/bbac174 (2022).","journal-title":"Brief. Bioinform."},{"key":"61161_CR49","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fimmu.2020.00071","volume":"11","author":"D Kaur","year":"2020","unstructured":"Kaur, D., Arora, C. & Raghava, G. P. S. A hybrid model for predicting pattern recognition receptors using evolutionary information. Front. Immunol. 11, 71. https:\/\/doi.org\/10.3389\/fimmu.2020.00071 (2020).","journal-title":"Front. Immunol."},{"key":"61161_CR50","doi-asserted-by":"publisher","first-page":"19421","DOI":"10.1038\/s41598-023-46408-1","volume":"13","author":"ER Basmenj","year":"2023","unstructured":"Basmenj, E. R. et al. Engineering and design of promising T-cell-based multi-epitope vaccine candidates against leishmaniasis. Sci. Rep. 13, 19421. https:\/\/doi.org\/10.1038\/s41598-023-46408-1 (2023a).","journal-title":"Sci. Rep."},{"key":"61161_CR51","doi-asserted-by":"publisher","unstructured":"Basmenj, E. R. et al. A novel approach to design a multiepitope peptide as a vaccine candidate for Bordetella pertussis. J. Biomol. Struct. Dyn. https:\/\/doi.org\/10.1080\/07391102.2023.2278081 (2023).","DOI":"10.1080\/07391102.2023.2278081"},{"issue":"8","key":"61161_CR52","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3390\/biology14081019","volume":"14","author":"D Trygoniaris","year":"2025","unstructured":"Trygoniaris, D. et al. VaccineDesigner: A web-based tool for streamlined multi-epitope vaccine design. Biology 14(8), 1019. https:\/\/doi.org\/10.3390\/biology14081019 (2025).","journal-title":"Biology"},{"issue":"1","key":"61161_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-8-361","volume":"8","author":"HH Bui","year":"2007","unstructured":"Bui, H. H., Sidney, J., Li, W., Fusseder, N. & Sette, A. Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines. BMC Bioinformatics 8(1), 361 (2007).","journal-title":"BMC Bioinformatics"},{"issue":"2","key":"61161_CR54","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3390\/vaccines11020203","volume":"11","author":"MA Bakkari","year":"2023","unstructured":"Bakkari, M. A. Targeted protein-specific multi-epitope-based vaccine designing against human cytomegalovirus by using immunoinformatics approaches. Vaccines 11(2), 203. https:\/\/doi.org\/10.3390\/vaccines11020203 (2023).","journal-title":"Vaccines"},{"issue":"1","key":"61161_CR55","doi-asserted-by":"publisher","first-page":"e162036","DOI":"10.5812\/ijpr-162036","volume":"24","author":"L Sadeghi","year":"2025","unstructured":"Sadeghi, L., Heidarnejad, F., Bolhassani, A., Mohit, E. & Moradi Pordanjani, P. In silico analysis of tat exons to increase the efficacy of a Nef-Tat-based HIV-1 vaccine candidate. Iran. J. Pharm. research: IJPR. 24(1), e162036. https:\/\/doi.org\/10.5812\/ijpr-162036 (2025).","journal-title":"Iran. J. Pharm. research: IJPR"},{"key":"61161_CR56","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.11126","volume":"9","author":"V Solanki","year":"2021","unstructured":"Solanki, V., Tiwari, M. & Tiwari, V. Immunoinformatic approach to design a multiepitope vaccine targeting non-mutational hotspot regions of structural and non-structural proteins of the SARS CoV2. PeerJ 9, e11126. https:\/\/doi.org\/10.7717\/peerj.11126 (2021).","journal-title":"PeerJ"},{"key":"61161_CR57","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12984","author":"SK Dhanda","year":"2018","unstructured":"Dhanda, S. K. et al. Alessandro Sette: Development of a novel clustering tool for linear peptide sequences. Immunology https:\/\/doi.org\/10.1111\/imm.12984 (2018).","journal-title":"Immunology"},{"issue":"8","key":"61161_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1789","volume":"14","author":"H Kumar","year":"2024","unstructured":"Kumar, H. & Kim, P. Artificial intelligence in fusion protein three-dimensional structure prediction: Review and perspective. Clin. Transl. Med. 14(8), e1789. https:\/\/doi.org\/10.1002\/ctm2.1789 (2024).","journal-title":"Clin. Transl. Med."},{"key":"61161_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjac.2025.100678","author":"PE Owona","year":"2025","unstructured":"Owona, P. E. et al. Phytoestrogens 7-O-acetylformonetin and khrinone A from Pterocarpus soyauxii Taub. inhibit the human papillomavirus replication: an integrative immunological, chemical, and computational approach to cervical cancer prevention. Chin. J. Anal. Chem. https:\/\/doi.org\/10.1016\/j.cjac.2025.100678 (2025).","journal-title":"Chin. J. Anal. Chem."},{"issue":"1\u20132","key":"61161_CR60","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/0014-5793(90)80535-q","volume":"276","author":"AS Kolaskar","year":"1990","unstructured":"Kolaskar, A. S. & Tongaonkar, P. C. A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett. 276(1\u20132), 172\u2013174. https:\/\/doi.org\/10.1016\/0014-5793(90)80535-q (1990).","journal-title":"FEBS Lett."},{"issue":"1","key":"61161_CR61","doi-asserted-by":"publisher","first-page":"e162036","DOI":"10.5812\/ijpr-162036","volume":"24","author":"L Sadeghi","year":"2025","unstructured":"Sadeghi, L., Heidarnejad, F., Bolhassani, A., Mohit, E. & Moradi Pordanjani, P. In silico analysis of tat exons to increase the efficacy of a Nef-Tat-based HIV-1 vaccine candidate. Iran. J. Pharm. research: IJPR. 24(1), e162036. https:\/\/doi.org\/10.5812\/ijpr-162036 (2025).","journal-title":"Iran. J. Pharm. research: IJPR"},{"key":"61161_CR62","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.11126","volume":"9","author":"V Solanki","year":"2021","unstructured":"Solanki, V., Tiwari, M. & Tiwari, V. Immunoinformatic approach to design a multiepitope vaccine targeting non-mutational hotspot regions of structural and non-structural proteins of the SARS CoV2. PeerJ 9, e11126. https:\/\/doi.org\/10.7717\/peerj.11126 (2021).","journal-title":"PeerJ"},{"issue":"10","key":"61161_CR63","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","volume":"51","author":"RA Laskowski","year":"2011","unstructured":"Laskowski, R. A. & Swindells, M. B. LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J. Chem. Inf. Model. 51(10), 2778\u20132786. https:\/\/doi.org\/10.1021\/ci200227u (2011).","journal-title":"J. Chem. Inf. Model."},{"issue":"Pt B","key":"61161_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.120407","volume":"353","author":"OP Emmanuel","year":"2025","unstructured":"Emmanuel, O. P. et al. Anti-breast cancer effects of Pterocarpus soyauxii Taub aqueous extract and its compounds by integrating ADMET, network pharmacology, molecular docking, dynamic simulation, CLC-Pred and pdCSM-Cancer\/PPI approaches, and in vitro validation. J. Ethnopharmacol. 353(Pt B), 120407. https:\/\/doi.org\/10.1016\/j.jep.2025.120407 (2025).","journal-title":"J. Ethnopharmacol."},{"key":"61161_CR65","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.csbj.2023.01.019","volume":"21","author":"BT Andongma","year":"2023","unstructured":"Andongma, B. T. et al. In silico design of a promiscuous chimeric multi-epitope vaccine against Mycobacterium tuberculosis. Comput. Struct. Biotechnol. J. 21, 991\u20131004. https:\/\/doi.org\/10.1016\/j.csbj.2023.01.019 (2023).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"61161_CR66","doi-asserted-by":"publisher","first-page":"W526","DOI":"10.1093\/nar\/gki376","volume":"33","author":"A Grote","year":"2005","unstructured":"Grote, A. et al. JCat: a novel tool to adapt codon usage of a target gene to its potential expression host. Nucleic Acids Res. 33, W526\u2013W531. https:\/\/doi.org\/10.1093\/nar\/gki376 (2005). Web Server issue.","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"61161_CR67","doi-asserted-by":"publisher","DOI":"10.1007\/s10989-021-10344-3","volume":"28","author":"A Lari","year":"2022","unstructured":"Lari, A., Lari, N. & Biabangard, A. Immunoinformatics approach to design a novel subunit vaccine against visceral leishmaniasis. Int. J. Pept. Res. Ther. 28(1), 34. https:\/\/doi.org\/10.1007\/s10989-021-10344-3 (2022).","journal-title":"Int. J. Pept. Res. Ther."},{"issue":"1","key":"61161_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-03672-7","volume":"15","author":"S Mirzaie","year":"2025","unstructured":"Mirzaie, S., Yuan, K. D., Ni, H. & Wu, X. Y. Design of a novel multiepitope vaccine against glioblastoma by in silico approaches. Sci. Rep. 15(1), 24046. https:\/\/doi.org\/10.1038\/s41598-025-03672-7 (2025).","journal-title":"Sci. Rep."},{"key":"61161_CR69","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/s41573-024-01042-y","volume":"23","author":"N Pardi","year":"2024","unstructured":"Pardi, N. & Krammer, F. mRNA vaccines for infectious diseases \u2014 advances, challenges and opportunities. Nat. Rev. Drug Discov. 23, 838\u2013861. https:\/\/doi.org\/10.1038\/s41573-024-01042-y (2024).","journal-title":"Nat. Rev. Drug Discov"},{"issue":"5","key":"61161_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13051147","volume":"13","author":"D Chundru","year":"2025","unstructured":"Chundru, D. et al. In silico design, optimization, and evaluation of a multi-epitope vaccine targeting the Clostridium perfringens collagen adhesin protein. Microorganisms 13(5), 1147. https:\/\/doi.org\/10.3390\/microorganisms13051147 (2025).","journal-title":"Microorganisms"},{"issue":"2","key":"61161_CR71","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.virol.2012.09.024","volume":"435","author":"S Sharma","year":"2013","unstructured":"Sharma, S., Wisner, T. W., Johnson, D. C. & Heldwein, E. E. HCMV gB shares structural and functional properties with other herpesvirus gB proteins. Virology 435(2), 239\u2013249. https:\/\/doi.org\/10.1016\/j.virol.2012.09.024 (2013).","journal-title":"Virology"},{"issue":"3","key":"61161_CR72","doi-asserted-by":"publisher","first-page":"e00332","DOI":"10.1128\/mBio.00332-13","volume":"4","author":"PT Wille","year":"2013","unstructured":"Wille, P. T., Wisner, T. W., Ryckman, B. & Johnson, D. C. HCMV glycoprotein gB promotes virus entry in trans acting as fusion protein. mBio 4(3), e00332\u2013e00313. https:\/\/doi.org\/10.1128\/mBio.00332-13 (2013).","journal-title":"mBio"},{"key":"61161_CR73","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ebiom.2019.11.005","volume":"50","author":"I Baraniak","year":"2019","unstructured":"Baraniak, I. et al. Neutralizing antibody responses after gB-MF59 vaccination in seronegative patients. EBioMedicine 50, 45\u201354 (2019).","journal-title":"EBioMedicine"},{"issue":"1","key":"61161_CR74","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2352908","volume":"20","author":"L Zhu","year":"2024","unstructured":"Zhu, L. et al. Design and evaluation of a multi-epitope DNA vaccine against HPV16. Hum. Vaccin. Immunother. 20(1), 2352908. https:\/\/doi.org\/10.1080\/21645515.2024.2352908 (2024).","journal-title":"Hum. Vaccin. Immunother."},{"issue":"9","key":"61161_CR75","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.20892\/j.issn.2095-3941.2025.0370","volume":"22","author":"L Zhu","year":"2025","unstructured":"Zhu, L. et al. A therapeutic multi-epitope protein vaccine targeting HPV16 E6 E7 elicits potent tumor regression and cytotoxic immune responses. Cancer biology Med. 22(9), 1102\u20131126 (2025).","journal-title":"Cancer biology Med."},{"issue":"15","key":"61161_CR76","doi-asserted-by":"publisher","first-page":"7945","DOI":"10.1080\/07391102.2023.2241926","volume":"42","author":"ER Basmenj","year":"2024","unstructured":"Basmenj, E. R., Omidvar, B., Kiumarsy, A., Izadkhah, H. & Ghiabi, S. Design of a multi-epitope-based peptide vaccine against the SARS-CoV-2 Omicron variant using bioinformatics approach. J. Biomol. Struct. Dyn. 42(15), 7945\u20137956. https:\/\/doi.org\/10.1080\/07391102.2023.2241926 (2024).","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"1","key":"61161_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-17066-2","volume":"15","author":"MS Hajizade","year":"2025","unstructured":"Hajizade, M. S., Rahbar, M. R., Kabiri, M., Hajimonfarednejad, M. & Raee, M. J. Epitope mapping strategies for immunogenicity mitigation in streptokinase therapeutics: An in-silico study. Sci. Rep. 15(1), 33499. https:\/\/doi.org\/10.1038\/s41598-025-17066-2 (2025).","journal-title":"Sci. Rep."},{"issue":"8","key":"61161_CR78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0272582","volume":"17","author":"A Ghasemian","year":"2022","unstructured":"Ghasemian, A., Farjadfar, A., Barzegari, E., Kouhpayeh, A. & Abdolmaleki, P. Design of a novel multi-epitope vaccine candidate against hepatitis C virus using structural and nonstructural proteins: An immunoinformatics approach. PLoS One 17(8), e0272582. https:\/\/doi.org\/10.1371\/journal.pone.0272582 (2022).","journal-title":"PLoS One"},{"issue":"2","key":"61161_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9020152","volume":"9","author":"S Gupta","year":"2020","unstructured":"Gupta, S., Mohan, S., Somani, V. K., Aggarwal, S. & Bhatnagar, R. Simultaneous immunization with Omp25 and L7\/L12 provides protection against brucellosis in mice. Pathogens (Basel, Switzerland) 9(2), 152. https:\/\/doi.org\/10.3390\/pathogens9020152 (2020).","journal-title":"Pathogens (Basel, Switzerland)"},{"key":"61161_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrep.2025.101966","volume":"42","author":"G Fatahi","year":"2025","unstructured":"Fatahi, G. et al. Designing of an efficient DC-inducing multi-epitope vaccine against Epstein Barr virus targeting the GP350 using immunoinformatics and molecular dynamic simulation. Biochem. Biophys. Rep. 42, 101966. https:\/\/doi.org\/10.1016\/j.bbrep.2025.101966 (2025).","journal-title":"Biochem. Biophys. Rep."},{"issue":"12","key":"61161_CR81","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1038\/nchembio.1685","volume":"10","author":"S Horiya","year":"2014","unstructured":"Horiya, S., MacPherson, I. S. & Krauss, I. J. Recent strategies targeting HIV glycans in vaccine design. Nat. Chem. Biol. 10(12), 990\u2013999. https:\/\/doi.org\/10.1038\/nchembio.1685 (2014).","journal-title":"Nat. Chem. Biol."},{"key":"61161_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2023.108283","volume":"70","author":"ML Newby","year":"2024","unstructured":"Newby, M. L., Allen, J. D. & Crispin, M. Influence of glycosylation on the immunogenicity and antigenicity of viral immunogens. Biotechnol. Adv. 70, 108283. https:\/\/doi.org\/10.1016\/j.biotechadv.2023.108283 (2024).","journal-title":"Biotechnol. Adv."},{"key":"61161_CR83","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3389\/fimmu.2015.00535","volume":"6","author":"F Osorio","year":"2015","unstructured":"Osorio, F., Fuentes, C., L\u00f3pez, M. N., Salazar-Onfray, F. & Gonz\u00e1lez, F. E. Role of dendritic cells in the induction of lymphocyte tolerance. Front. Immunol. 6, 535. https:\/\/doi.org\/10.3389\/fimmu.2015.00535 (2015).","journal-title":"Front. Immunol."},{"key":"61161_CR84","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.11765","volume":"5","author":"I Streng-Ouwehand","year":"2016","unstructured":"Streng-Ouwehand, I. et al. Glycan modification of antigen alters its intracellular routing in dendritic cells, promoting priming of T cells. eLife 5, e11765. https:\/\/doi.org\/10.7554\/eLife.11765 (2016).","journal-title":"eLife"},{"issue":"10","key":"61161_CR85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002999","volume":"8","author":"B Kropff","year":"2012","unstructured":"Kropff, B. et al. Glycoprotein N of human cytomegalovirus protects the virus from neutralizing antibodies. PLoS Pathog. 8(10), e1002999. https:\/\/doi.org\/10.1371\/journal.ppat.1002999 (2012).","journal-title":"PLoS Pathog."},{"issue":"9","key":"61161_CR86","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.3390\/v17091209","volume":"17","author":"CS Oliveira","year":"2025","unstructured":"Oliveira, C. S., Sakauchi, D., Sasaki, \u00c9. A. K. & Cianciarullo, A. M. Recombinant chimeric virus-like particles of human papillomavirus produced by distinct cell lineages: potential as prophylactic nanovaccine and therapeutic drug nanocarriers. Viruses 17(9), 1209. https:\/\/doi.org\/10.3390\/v17091209 (2025).","journal-title":"Viruses"},{"key":"61161_CR87","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1126034","volume":"14","author":"CE Martina","year":"2023","unstructured":"Martina, C. E., Crowe, J. E. Jr. & Meiler, J. Glycan masking in vaccine design: Targets, immunogens and applications. Front. Immunol. 14, 1126034. https:\/\/doi.org\/10.3389\/fimmu.2023.1126034 (2023).","journal-title":"Front. Immunol."},{"issue":"1","key":"61161_CR88","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/mlf2.12105","volume":"3","author":"A Ming","year":"2024","unstructured":"Ming, A. et al. O-glycosylation in viruses: A sweet tango. mLife 3(1), 57\u201373. https:\/\/doi.org\/10.1002\/mlf2.12105 (2024).","journal-title":"mLife"},{"issue":"12","key":"61161_CR89","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.3390\/jpm11121253","volume":"11","author":"RM Gorczynski","year":"2021","unstructured":"Gorczynski, R. M., Lindley, R. A., Steele, E. J. & Wickramasinghe, N. C. Nature of acquired immune responses, epitope specificity and resultant protection from SARS-CoV-2. J. personalized Med. 11(12), 1253. https:\/\/doi.org\/10.3390\/jpm11121253 (2021).","journal-title":"J. personalized Med."},{"issue":"1","key":"61161_CR90","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2024.2324836","volume":"16","author":"R Sun","year":"2024","unstructured":"Sun, R., Qian, M. G. & Zhang, X. T and B cell epitope analysis for the immunogenicity evaluation and mitigation of antibody-based therapeutics. MAbs 16(1), 2324836. https:\/\/doi.org\/10.1080\/19420862.2024.2324836 (2024).","journal-title":"MAbs"},{"issue":"1","key":"61161_CR91","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s40203-023-00156-2","volume":"11","author":"AR Yaseen","year":"2023","unstructured":"Yaseen, A. R. et al. Development of conserved multi-epitopes based hybrid vaccine against SARS-CoV-2 variants: an immunoinformatic approach. silico Pharmacol. 11(1), 18. https:\/\/doi.org\/10.1007\/s40203-023-00156-2 (2023).","journal-title":"silico Pharmacol."},{"key":"61161_CR92","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-025-11066-3","volume":"25","author":"S Mohammadipour","year":"2025","unstructured":"Mohammadipour, S., Tavakkoli, H., Fatemi, S. N., Sharifi, A. & Mahmoudi, P. Designing a multi-epitope universal vaccine for concurrent infections of SARS-CoV-2 and influenza viruses using an immunoinformatics approach. BMC Infect. Dis. 25, 688. https:\/\/doi.org\/10.1186\/s12879-025-11066-3 (2025).","journal-title":"BMC Infect. Dis."},{"key":"61161_CR93","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.6185","volume":"6","author":"Y Lei","year":"2019","unstructured":"Lei, Y. et al. Application of built-in adjuvants for epitope-based vaccines. PeerJ 6, e6185. https:\/\/doi.org\/10.7717\/peerj.6185 (2019).","journal-title":"PeerJ"},{"key":"61161_CR94","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.virol.2022.05.001","volume":"572","author":"K Khan","year":"2022","unstructured":"Khan, K., Khan, S. A., Jalal, K., Ul-Haq, Z. & Uddin, R. Immunoinformatic approach for the construction of multi-epitopes vaccine against omicron COVID-19 variant. Virology 572, 28\u201343. https:\/\/doi.org\/10.1016\/j.virol.2022.05.001 (2022).","journal-title":"Virology"},{"key":"61161_CR95","doi-asserted-by":"publisher","first-page":"107172","DOI":"10.1016\/j.ejps.2025.107172","volume":"212","author":"S Yoo","year":"2025","unstructured":"Yoo, S. et al. Artificial intelligence-driven discovery of novel scaffolds for selective TLR7 antagonists and their application in enhancing mRNA translation efficiency. Eur. J. Pharm. sciences: official J. Eur. Federation Pharm. Sci. 212, 107172. https:\/\/doi.org\/10.1016\/j.ejps.2025.107172 (2025).","journal-title":"Eur. J. Pharm. sciences: official J. Eur. Federation Pharm. Sci."},{"issue":"1","key":"61161_CR96","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4103\/jgid.jgid_96_21","volume":"14","author":"S Srinivasan","year":"2022","unstructured":"Srinivasan, S. et al. Epitope identification and designing a potent multi-epitope vaccine construct against SARS-CoV-2 including the emerging variants. J. Glob. Infect. Dis. 14(1), 24\u201330. https:\/\/doi.org\/10.4103\/jgid.jgid_96_21 (2022).","journal-title":"J. Glob. Infect. Dis."},{"key":"61161_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrep.2025.101966","volume":"42","author":"G Fatahi","year":"2025","unstructured":"Fatahi, G. et al. Designing of an efficient DC-inducing multi-epitope vaccine against Epstein Barr virus targeting the GP350 using immunoinformatics and molecular dynamic simulation. Biochem. Biophys. Rep. 42, 101966. https:\/\/doi.org\/10.1016\/j.bbrep.2025.101966 (2025).","journal-title":"Biochem. Biophys. Rep."},{"issue":"2","key":"61161_CR98","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3390\/pathogens11020134","volume":"11","author":"I Mart\u00ednez-Espinoza","year":"2022","unstructured":"Mart\u00ednez-Espinoza, I. & Guerrero-Plata, A. The relevance of TLR8 in viral infections. Pathogens 11(2), 134. https:\/\/doi.org\/10.3390\/pathogens11020134 (2022).","journal-title":"Pathogens"},{"key":"61161_CR99","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s40364-022-00436-7","volume":"10","author":"H Sun","year":"2022","unstructured":"Sun, H. et al. Targeting TLR7\/8 for immunotherapy: advances and perspectives. Biomark. Res. 10, 89. https:\/\/doi.org\/10.1186\/s40364-022-00436-7 (2022).","journal-title":"Biomark. Res."},{"issue":"40","key":"61161_CR100","doi-asserted-by":"publisher","first-page":"16276","DOI":"10.1073\/pnas.1209372109","volume":"109","author":"ER Walsh","year":"2012","unstructured":"Walsh, E. R. et al. Dual signaling by innate and adaptive immune receptors in TLR7-induced B-cell autoimmunity. PNAS 109(40), 16276\u201316281 (2012).","journal-title":"PNAS"},{"key":"61161_CR101","doi-asserted-by":"publisher","first-page":"112238","DOI":"10.1016\/j.ejmech.2020.112238","volume":"193","author":"C Patinote","year":"2020","unstructured":"Patinote, C. et al. Agonist and antagonist ligands of TLR7 and TLR8. Eur. J. Med. Chem. 193, 112238 (2020).","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"61161_CR102","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3390\/vaccines13030248","volume":"13","author":"J Li","year":"2025","unstructured":"Li, J., Ju, Y., Jiang, M., Li, S. & Yang, X. Y. Epitope-based vaccines: next-generation approaches. Vaccines 13(3), 248 (2025).","journal-title":"Vaccines"},{"key":"61161_CR103","doi-asserted-by":"publisher","first-page":"10297","DOI":"10.1038\/s41598-024-61025-2","volume":"14","author":"J Sarvmeili","year":"2024","unstructured":"Sarvmeili, J., Baghban Kohnehrouz, B., Gholizadeh, A., Shanehbandi, D. & Ofoghi, H. Immunoinformatics design of multi-epitope SARS-CoV-2 vaccine. Sci. Rep. 14, 10297 (2024).","journal-title":"Sci. Rep."},{"key":"61161_CR104","doi-asserted-by":"publisher","first-page":"15072","DOI":"10.1038\/s41598-026-45572-4","volume":"16","author":"S Kousar","year":"2026","unstructured":"Kousar, S. et al. Immunoinformatic-based multi-epitope vaccine against Ruminococcus torques. Sci. Rep. 16, 15072 (2026).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61161-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61161-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61161-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T11:50:02Z","timestamp":1784202602000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61161-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":104,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["61161"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-61161-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"9 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"22402"}}